Ovid Therapeutics
OVID
#9224
Rank
NZ$0.11 B
Marketcap
$1.68
Share price
-4.94%
Change (1 day)
-68.74%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2023 (TTM): -$1.15

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.24. In 2022 the company made an earnings per share (EPS) of -$1.36 a decrease over its 2021 EPS that were of $3.14.

EPS history for Ovid Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.15-15.9%
2022-$1.36-143.5%
2021$3.14-226.43%
2020-$2.48-11.39%
2019-$2.80-25.47%
2018-$3.76-23.94%
2017-$4.94143.74%
2016-$2.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.86 211.43%๐Ÿ‡บ๐Ÿ‡ธ USA